Chris Freeman, Chief Commercial Officer at Guardant Health, Inc. (GH), sold 63,605 shares at $167.38 ($10.8M) on 2026-08-10, disclosed to the SEC on 2026-08-11.
Open-market sale of $10.8M GH by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $167.38 | 3,463 | $580K | 5.4% |
| 2 | $168.79 | 7,365 | $1.2M | 11.5% |
| 3 | $169.63 | 35,364 | $6.0M | 55.6% |
| 4 | $170.24 | 17,413 | $3.0M | 27.5% |
| Total | $169.58 avg | 63,605 | $10.8M | 100% |
| Filing → |